Towards a Comprehensive Hydride Donor Ability Scale
作者:Markus Horn、Ludwig H. Schappele、Gabriele Lang-Wittkowski、Herbert Mayr、Armin R. Ofial
DOI:10.1002/chem.201202839
日期:2013.1.2
Rates of hydride transfer from several hydridedonors to benzhydrylium ions have been measured at 20 °C and used for the determination of empirical nucleophilicity parameters N and sN according to the linear free energy relationship log k20 °C=sN(N+E). Comparison of the rate constants of hydride abstraction by tritylium ions with those calculated from the reactivity parameters sN, N, and E showed fair
Novel Inhibitors of the Gardos Channel for the Treatment of Sickle Cell Disease
作者:Grant A. McNaughton-Smith、J. Ford Burns、Jonathan W. Stocker、Gregory C. Rigdon、Christopher Creech、Susan Arrington、Tara Shelton、Lucia de Franceschi
DOI:10.1021/jm070663s
日期:2008.2.1
Sickle cell disease (SCD) is a hereditary condition characterized by deformation of red blood cells (RBCs). This phenomenon is due to the presence of abnormal hemoglobin that polymerizes upon deoxygenation. This effect is exacerbated when dehydrated RBCs experience a loss of both water and potassium salts. One critical pathway for the regulation of potassium efflux from RBCs is the Gardos channel, a calcium-activated potassium channel. This paper describes the synthesis and biological evaluation of a series of potent inhibitors of the Gardos channel. The goal was to identify compounds that were potent and selective inhibitors of the channel but had improved pharmacokinetic properties compared to 1, Clotrimazole. Several triarylamides such as 10 and 21 were potent inhibitors of the Gardos channel (IC50 of < 10 nM) and active in a mouse model of SCD. Compound 21 (ICA-17043) was advanced into phase 3 clinical trials for SCD.
BARTROLL, JAVIER;ANGULTA, MANUEL
作者:BARTROLL, JAVIER、ANGULTA, MANUEL
DOI:——
日期:——
The Dissociation of Hexaarylethanes. XVI.<sup>1</sup> Alkyl and Halogen Derivatives
作者:C. S. Marvel、H. W. Johnston、J. W. Meier、T. W. Mastin、John Whitson、Chester M. Himel